The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study
Summary Background Genetic testing in breast cancer patients is important for the patient’s local and systemic treatment choices and follow-up, as well as for their family members. Not all eligible patients currently undergo genetic testing and disparities persist in genetic testing uptake. It is un...
Saved in:
| Main Authors: | Chiem Leonardo de Jong, Sabine Siesling, Ghita Carola Wilhelmina Maria Puts, Agnes Jager, Margreet Geertruda Elia Maria Ausems |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Breast Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13058-025-02081-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action
by: Evan Weber, et al.
Published: (2025-05-01) -
Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing
by: Callan D. Russell, et al.
Published: (2024-11-01) -
BRCA cascade counselling and testing in Italy: current position and future directions
by: Silvia Costanzo, et al.
Published: (2025-07-01) -
Health care providers’ experiences with genetic testing in patients at risk for hereditary angioedema
by: Dawn A. Laney, MS, et al.
Published: (2025-05-01) -
Genetics healthcare providers' experiences counseling patients with results from consumer genomic testing
by: Magan Trottier, et al.
Published: (2024-08-01)